Dentsply Sirona Stock

$16.21

2.47% day before yesterday

Nasdaq, Jul 11, 10:00 pm CET

ISIN

US24906P1093

Symbol

XRAY

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Dentsply Sirona Stock price

$16.21

-25.59 61.22% 5Y

Nasdaq, Closing price Fri, Jul 11 2025

-0.41 2.47%

ISIN

US24906P1093

Symbol

XRAY

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

$3.2b

Enterprise Value

$5.2b

Net debt

$1.9b

Cash

$398.0m

Shares outstanding

199.3m

Valuation (TTM | estimate)

P/E

negative | 8.4

P/S

0.9 | 0.9

EV/Sales

1.4 | 1.4

EV/FCF

18.6

P/B

1.6

Dividends

DPS

$0.64

Yield 1Y | 5Y

4.0% | 1.2%

Growth 1Y | 5Y

14.3% | 11.3%

Payout 1Y | 3Y

-14.3% | -17.9%

Increased

6 Years

Financials (TTM | estimate)

Revenue

$3.7b | $3.7b

EBITDA

$593.0m | $710.5m

EBIT

$251.0m | $564.4m

Net Income

$-908.0m | $385.7m

Free Cash Flow

$278.0m

Growth (TTM | estimate)

Revenue

-5.6% | -1.8%

EBITDA

-5.9% | 22.7%

EBIT

-11.9% | 145.4%

Net Income

-855.8% | 142.4%

Free Cash Flow

-0.4%

Financial Health

Equity Ratio

33.8%

Return on Equity

-46.9%

ROCE

5.9%

ROIC

4.7%

Debt/Equity

1.2

EPS

$-4.5

FCF per Share

$1.4

Short interest

4.7%

Employees

14k

Rev per Employee

$270.0k

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Dentsply Sirona Stock Analysis

Unlock Scores for Free

??

23 Analysts have issued a Dentsply Sirona forecast:

8x Buy

35%

15x Hold

65%

More details on Analyst Estimates Including Price Targets

23 Analysts have issued a Dentsply Sirona forecast:

Buy

35%

Hold

65%

Analyst Estimates with Stock Price Targets

Financial data from Dentsply Sirona

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	3,719 3,719	6% 6% 100%
- Direct Costs	1,791 1,791	4% 4% 48%
Gross Profit	1,928 1,928	7% 7% 52%
- Selling and Administrative Expenses	1,518 1,518	6% 6% 41%
- Research and Development Expense	159 159	12% 12% 4%
EBITDA	593 593	6% 6% 16%
- Depreciation and Amortization	342 342	1% 1% 9%
EBIT (Operating Income) EBIT	251 251	12% 12% 7%
Net Profit	-908 -908	856% 856% -24%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Dentsply Sirona Stock News

Neutral

GlobeNewsWire

●

3 days ago

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation ...

Neutral

Accesswire

●

about one month ago

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY

PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Dentsply Sirona Inc. (NASDAQ:XRAY) ("Dentsply") on behalf of the company's long-term investors. Click here to receive additional information about your legal rights and options: https://kaskelalaw.com/case/dentsply-sirona/ Recently an amende...

Neutral

GlobeNewsWire

●

about one month ago

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”).

More Dentsply Sirona News

Company Profile

Dentsply Sirona, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in Charlotte, NC.

Head office	United States
CEO	Simon Campion
Employees	14,000
Founded	1899
Website	www.dentsplysirona.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now